JP2007522210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007522210A5 JP2007522210A5 JP2006553086A JP2006553086A JP2007522210A5 JP 2007522210 A5 JP2007522210 A5 JP 2007522210A5 JP 2006553086 A JP2006553086 A JP 2006553086A JP 2006553086 A JP2006553086 A JP 2006553086A JP 2007522210 A5 JP2007522210 A5 JP 2007522210A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- carboxamide
- methyl
- ethyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400284A SE0400284D0 (sv) | 2004-02-10 | 2004-02-10 | Novel compounds |
| PCT/SE2005/000156 WO2005075429A1 (en) | 2004-02-10 | 2005-02-07 | Novel quinoline-carbaxamides as jack3 kinase modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007522210A JP2007522210A (ja) | 2007-08-09 |
| JP2007522210A5 true JP2007522210A5 (https=) | 2008-03-21 |
Family
ID=31885281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006553086A Pending JP2007522210A (ja) | 2004-02-10 | 2005-02-07 | ＪＡＫ３キナーゼ修飾物質としての新規なキノリン−カルボキシアミド（ｃａｒｂａｘａｍｉｄｅ） |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080153799A1 (https=) |
| EP (1) | EP1718615A1 (https=) |
| JP (1) | JP2007522210A (https=) |
| CN (1) | CN1942445A (https=) |
| AR (1) | AR047609A1 (https=) |
| SE (1) | SE0400284D0 (https=) |
| TW (1) | TW200529838A (https=) |
| UY (1) | UY28745A1 (https=) |
| WO (1) | WO2005075429A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7297700B2 (en) | 2005-03-24 | 2007-11-20 | Renovis, Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| WO2007008926A1 (en) | 2005-07-11 | 2007-01-18 | Aerie Pharmaceuticals, Inc. | Isoquinoline compounds |
| TWI464148B (zh) | 2006-03-16 | 2014-12-11 | Evotec Us Inc | 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途 |
| SI2010496T1 (sl) * | 2006-04-14 | 2010-11-30 | Astrazeneca Ab | anilinokinolin karboksamidi kot inhibitorji CSF R kinaze |
| WO2008036540A2 (en) | 2006-09-20 | 2008-03-27 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
| TW200831488A (en) | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
| US8455513B2 (en) * | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
| JO2704B1 (en) | 2007-09-21 | 2013-03-03 | جانسين فارماسوتيكا ان في | Interference inhibition factors between MD2 and B53 |
| US8455514B2 (en) * | 2008-01-17 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| JPWO2010058846A1 (ja) * | 2008-11-21 | 2012-04-19 | アステラス製薬株式会社 | ４，６−ジアミノニコチンアミド化合物 |
| WO2010061971A1 (ja) | 2008-11-28 | 2010-06-03 | 興和株式会社 | ピリジン－３－カルボキシアミド誘導体 |
| EP3053913B1 (en) * | 2009-05-01 | 2018-03-07 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| US20120065199A1 (en) * | 2009-05-20 | 2012-03-15 | Clanotech Ab | Substituted quinolines for use as vegf inhibitors |
| WO2012061557A2 (en) * | 2010-11-05 | 2012-05-10 | Glaxosmithkline Llc | Chemical compounds |
| JP6669499B2 (ja) | 2013-02-15 | 2020-03-18 | カラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物 |
| JP2016510000A (ja) | 2013-02-20 | 2016-04-04 | カラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物およびその使用 |
| US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
| DK3811943T3 (da) | 2013-03-15 | 2023-04-03 | Aerie Pharmaceuticals Inc | Forbindelse til anvendelse til behandling af øjenlidelser |
| US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| NZ719185A (en) | 2013-11-01 | 2017-11-24 | Kala Pharmaceuticals Inc | Crystalline forms of therapeutic compounds and uses thereof |
| US10550087B2 (en) | 2015-11-17 | 2020-02-04 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
| US9643927B1 (en) | 2015-11-17 | 2017-05-09 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
| KR102568079B1 (ko) | 2016-08-31 | 2023-08-17 | 에어리 파마슈티컬즈, 인코포레이티드 | 안과용 조성물 |
| AU2017324713B2 (en) | 2016-09-08 | 2020-08-13 | KALA BIO, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| KR20190051010A (ko) | 2016-09-08 | 2019-05-14 | 칼라 파마슈티컬스, 인크. | 치료 화합물의 결정형 및 그의 용도 |
| EP3509423A4 (en) | 2016-09-08 | 2020-05-13 | Kala Pharmaceuticals, Inc. | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |
| KR20190135027A (ko) | 2017-03-31 | 2019-12-05 | 에어리 파마슈티컬즈, 인코포레이티드 | 아릴 시클로프로필-아미노-이소퀴놀리닐 아미드 화합물 |
| AU2019337703B2 (en) | 2018-09-14 | 2023-02-02 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
| CN111269215B (zh) * | 2020-04-01 | 2021-10-26 | 中科利健制药(广州)有限公司 | 含氮杂环有机化合物及其制备方法和应用 |
| TW202345806A (zh) | 2022-03-31 | 2023-12-01 | 美商艾伯維有限公司 | 噻唑并〔５，４－ｂ〕吡啶ｍａｌｔ－１抑制劑 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3362954A (en) * | 1965-08-12 | 1968-01-09 | Sterling Drug Inc | 4-tertiary amino-lower alkylamino-quinoline carboxamides and carboxylates |
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| GB8804447D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| DK273689A (da) * | 1988-06-06 | 1989-12-07 | Sanofi Sa | 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler |
| KR920701162A (ko) * | 1990-03-28 | 1992-08-11 | 오츠카 아끼히코 | 퀴놀린 유도체, 당해 유도체를 함유하는 항궤양제 및 당해 유도체의 제조방법 |
| UA73073C2 (uk) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| SE0101675D0 (sv) * | 2001-05-11 | 2001-05-11 | Astrazeneca Ab | Novel composition |
-
2004
- 2004-02-10 SE SE0400284A patent/SE0400284D0/xx unknown
-
2005
- 2005-02-04 TW TW094103740A patent/TW200529838A/zh unknown
- 2005-02-07 US US10/597,896 patent/US20080153799A1/en not_active Abandoned
- 2005-02-07 JP JP2006553086A patent/JP2007522210A/ja active Pending
- 2005-02-07 WO PCT/SE2005/000156 patent/WO2005075429A1/en not_active Ceased
- 2005-02-07 EP EP05704807A patent/EP1718615A1/en not_active Withdrawn
- 2005-02-07 CN CNA2005800119096A patent/CN1942445A/zh active Pending
- 2005-02-10 AR ARP050100489A patent/AR047609A1/es unknown
- 2005-02-10 UY UY28745A patent/UY28745A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007522210A5 (https=) | ||
| US20080153799A1 (en) | Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators | |
| ES2282649T3 (es) | Derivados de quinolina e isoquinolina, un procedimiento para su preparacion y su utilizacion como agentes anti-inflamatorios. | |
| US6897224B2 (en) | Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors | |
| CA2849169C (en) | Pyrazole carboxamides as janus kinase inhibitors | |
| EP1682545B1 (en) | Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation | |
| TWI449696B (zh) | 以５員雜環為主之ｐ３８激酶抑制劑 | |
| KR100417620B1 (ko) | 파르네실트랜스퍼라제억제기능을갖는2-퀴놀론유도체 | |
| JP2002506858A (ja) | Ｃｍｖ感染症の治療に有用な１，３，４−チアジアゾール | |
| JP2003507456A (ja) | ケモカインレセプター活性のモジュレーターとして有用な置換ピペリジン化合物 | |
| JP2003513090A (ja) | Ｎ置換カルバモイルオキシアルキルアゾリウム誘導体 | |
| CZ20011563A3 (cs) | Tricyklické pyrazolové deriváty | |
| MXPA02003533A (es) | Derivados de pirimidina. | |
| CN1473154A (zh) | 2,3-二氮杂萘酮衍生物 | |
| EP0634402A1 (en) | Isochinolinone derivatives, their production and use | |
| KR20010081034A (ko) | 피페리딘 씨씨알-3 수용체 길항제 | |
| AU2005316511B2 (en) | Compounds and compositions as modulators of steroidal receptors and calcium channel activities | |
| MX2008012031A (es) | Derivado de triazolona. | |
| JPWO2005087749A1 (ja) | ２−アミノキナゾリン誘導体 | |
| UA108746C2 (xx) | Заміщені ізохінолінони та хіназолінони | |
| JP2008501672A (ja) | ケモカイン受容体アンタゴニストとしてのチアゾール誘導体 | |
| WO1999054307A1 (en) | Pyrazolinone derivatives | |
| JP6200495B2 (ja) | α−置換グリシンアミド誘導体 | |
| JPH072788A (ja) | 新規な経口活性を有するアゾール誘導体 | |
| JP2004516322A (ja) | ファルネシルトランスフェラーゼを阻害する４−ヘテロシクリル−キノリンおよびキナゾリン誘導体 |